Clopidogrel bisulfate and Exercise tolerance decreased - a phase IV clinical study of FDA data

Summary:

Exercise tolerance decreased is reported as a side effect among people who take Clopidogrel bisulfate (clopidogrel bisulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Nucala, and have Prostatitis.

The phase IV clinical study analyzes which people have Exercise tolerance decreased when taking Clopidogrel bisulfate. It is created by eHealthMe based on reports of 17,862 people who have side effects when taking Clopidogrel bisulfate from the FDA, and is updated regularly.

What is Clopidogrel bisulfate?

Clopidogrel bisulfate has active ingredients of clopidogrel bisulfate. It is often used in blood clots. eHealthMe is studying from 18,075 Clopidogrel bisulfate users. Check the latest studies of Clopidogrel bisulfate.

What is Exercise tolerance decreased?

Exercise tolerance decreased is found to be associated with 625 drugs and 723 conditions by eHealthMe. Check the latest studies of Exercise tolerance decreased.

On Jul, 09, 2026

17,862 people reported to have side effects when taking Clopidogrel bisulfate.
Among them, 17 people (0.1%) have Exercise tolerance decreased.

Could Clopidogrel bisulfate cause Exercise tolerance decreased?

Among these 17 people:

How long have people been on Clopidogrel bisulfate when they have Exercise tolerance decreased? *

What is the gender of people who have Exercise tolerance decreased when taking Clopidogrel bisulfate? *

female: 5.88 %
male: 94.12 %

What is the age of people who have Exercise tolerance decreased when taking Clopidogrel bisulfate? *

What are other drugs people take besides Clopidogrel bisulfate? *

What are other side effects people have besides Exercise tolerance decreased? *

Dyspnea (difficult or laboured breathing): 15 people, 88.24%
Cough: 8 people, 47.06%
Asthma: 8 people, 47.06%
Dyspnea Exertional: 8 people, 47.06%
Restrictive Pulmonary Disease (reduction in total lung capacity): 7 people, 41.18%
Orthopnea (shortness of breath (dyspnea) when lying down): 7 people, 41.18%
Peripheral Swelling: 7 people, 41.18%
Drug Ineffective: 7 people, 41.18%
Pulmonary Mass: 7 people, 41.18%
Dyskinesia Oesophageal (abnormality or impairment of voluntary movement of oesophageal): 7 people, 41.18%

What are the existing conditions these people have? *

Respiratory Disorder (respiratory disease): 7 people, 41.18%
Prostatitis (inflammation of the prostate gland): 7 people, 41.18%
Infective Exacerbation Of Chronic Obstructive Airways Disease (severe infective lung disease with chronic obstructive airways disease): 6 people, 35.29%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 2 people, 11.76%
Hypertensive Heart Disease: 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%
Chronic Kidney Disease: 1 person, 5.88%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel bisulfate and have Exercise tolerance decreased?

- Check whether Exercise tolerance decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel bisulfate:

Clopidogrel bisulfate (18,075 reports)

Browse all side effects of Clopidogrel bisulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (625 drugs)

Browse all the conditions that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate (the active ingredients of Clopidogrel bisulfate) and Clopidogrel bisulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.